Cancer Treatment Reviews
Volume 31, Issue 8 , Pages 648-652, December 2005

Adjuvant capecitabine is at least as effective as fluorouracil plus leucovorin for survival in people with resected stage III colon cancer☆☆☆☆☆☆

  • C. Lamberti

      Affiliations

    • Corresponding Author InformationCorresponding author: Present address. Department of Internal Medicine I, University of Bonn, Sigmund-Freud-Str. 25, D-53105 Bonn, Germany. Tel.: +49 228 287 9098; fax: +49 228 287 9025.
    • ,
  • T. Sauerbruch
    • ,
  • A Glasmacher

Department of Internal Medicine I, University of Bonn, Germany

published online 15 November 2005.

Abstracted from: Twelves C, Wong A, Nowacki MP, Abt M, Burris H, Carrato A et al. Capecitabine as adjuvant treatment for stage III colon cancer. New Engl J Med 2005;352:2696–704.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Sources of funding: Hoffmann–La Roche.

☆☆ For correspondence: Dr. Twelves, Tom Connors Cancer Research Centre, University of Bradford, Richmond Road, Bradford BD7 1DP, UK; e-mail: c.twelves@bradford.ac.uk.

☆☆☆ Abstract provided by Bazian Ltd., London.

PII: S0305-7372(05)00196-9

doi:10.1016/j.ctrv.2005.09.009

Cancer Treatment Reviews
Volume 31, Issue 8 , Pages 648-652, December 2005

Article Tools